GRRMF

Gerresheimer AG

Healthcare · $1.0B market cap

Share price

$29.05

close of Oct 1, 2026

Fair value

$24.20

Sticker Price

Payback Price

$9.68

buy price

Overpriced

GRRMF is Overpriced: at $29.05 it trades 20% above its fair value of $24.20. Its buy price (Payback Price) is $9.68, 67% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth6.0% a year✗

Equity per share growth7.9% a year✗

Sales growth4.5% a year✗

Free cash flow growth-3.0% a year✗

Return on invested capital1.5%✗

Follow GRRMF

Get notified when it reaches its buy price of $9.68. Free.

Create a free account

About Gerresheimer AG

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 1, 2026. How the Payback Price works

Verdict

How we valued it

Business quality

About Gerresheimer AG